These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29554042)

  • 1. Effects of platelet-sparing leukocyte reduction and agitation methods on in vitro measures of hemostatic function in cold-stored whole blood.
    Remy KE; Yazer MH; Saini A; Mehanovic-Varmaz A; Rogers SR; Cap AP; Spinella PC
    J Trauma Acute Care Surg; 2018 Jun; 84(6S Suppl 1):S104-S114. PubMed ID: 29554042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic potential of cold-stored non-leukoreduced whole blood over time: An assessment of platelet function and thrombin generation for optimal shelf life.
    Assen S; Cardenas J; George M; Wang YW; Wade CE; Meyer D; Cotton BA
    J Trauma Acute Care Surg; 2020 Sep; 89(3):429-434. PubMed ID: 32467473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of leukoreduced whole blood for transfusion in austere environments; effects of forced filtration, storage agitation, and high temperatures on hemostatic function.
    Sivertsen J; Braathen H; Lunde THF; Spinella PC; Dorlac W; Strandenes G; Apelseth TO; Hervig TA; Kristoffersen EK
    J Trauma Acute Care Surg; 2018 Jun; 84(6S Suppl 1):S93-S103. PubMed ID: 29538232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of leukoreduction and pathogen reduction on the hemostatic function of whole blood.
    Thomas KA; Shea SM; Yazer MH; Spinella PC
    Transfusion; 2019 Apr; 59(S2):1539-1548. PubMed ID: 30980757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cold-stored leukoreduced CPDA-1 whole blood: in vitro quality and hemostatic properties.
    Sivertsen J; Braathen H; Lunde THF; Kristoffersen EK; Hervig T; Strandenes G; Apelseth TO
    Transfusion; 2020 May; 60(5):1042-1049. PubMed ID: 32187700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of whole blood leukoreduction on platelet function and hemostatic parameters.
    Morris MC; Veile R; Friend LA; Oh D; Pritts TA; Dorlac WC; Spinella PC; Goodman MD
    Transfus Med; 2019 Oct; 29(5):351-357. PubMed ID: 31382318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation in whole blood is not impaired by a platelet-sparing leukoreduction filter and instead depends upon the presence of leukocytes.
    Rice J; Bill JR; Razatos A; Marschner S
    Transfusion; 2021 Jul; 61 Suppl 1():S90-S100. PubMed ID: 34269461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic properties of cold-stored whole blood leukoreduced using a platelet-sparing versus a non-platelet-sparing filter.
    Haddaway K; Bloch EM; Tobian AAR; Frank SM; Sikorski R; Cho BC; Zheng G; Jani J; Lokhandwala PM; Lawrence CE; Blagg L; Ness PM; Kickler TS; Gehrie EA
    Transfusion; 2019 May; 59(5):1809-1817. PubMed ID: 30741432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cold-stored platelet function is not significantly altered by agitation or manual mixing.
    Shea SM; Spinella PC; Thomas KA
    Transfusion; 2022 Sep; 62(9):1850-1859. PubMed ID: 35898113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cold-stored leukoreduced whole blood: Extending the time between donation and filtration has minimal impact on in vitro quality.
    Schubert P; Chen Z; Bhakta V; Culibrk B; Wambolt R; Sheffield WP; Devine DV; McTaggart K
    Transfusion; 2021 Jul; 61 Suppl 1():S131-S143. PubMed ID: 34269454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte filtration lesion impairs functional coagulation in banked whole blood.
    Siletz A; Burruss S; Gruber T; Ziman A; Marder V; Cryer HM
    J Trauma Acute Care Surg; 2017 Sep; 83(3):420-426. PubMed ID: 28452876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing whole blood storage: hemostatic function of 35-day stored product in CPD, CP2D, and CPDA-1 anticoagulants.
    Meledeo MA; Peltier GC; McIntosh CS; Bynum JA; Cap AP
    Transfusion; 2019 Apr; 59(S2):1549-1559. PubMed ID: 30980756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation function of stored whole blood is preserved for 14 days in austere conditions: A ROTEM feasibility study during a Norwegian antipiracy mission and comparison to equal ratio reconstituted blood.
    Strandenes G; Austlid I; Apelseth TO; Hervig TA; Sommerfelt-Pettersen J; Herzig MC; Cap AP; Pidcoke HF; Kristoffersen EK
    J Trauma Acute Care Surg; 2015 Jun; 78(6 Suppl 1):S31-8. PubMed ID: 26002261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticle profile and procoagulant activity of fresh-frozen plasma is affected by whole blood leukoreduction rather than 24-hour room temperature hold.
    Chan KS; Sparrow RL
    Transfusion; 2014 Aug; 54(8):1935-44. PubMed ID: 24635475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced platelet function in cold stored whole blood supplemented with resveratrol or cytochrome C.
    Ekaney ML; Gray GG; McKillop IH; Evans SL
    J Trauma Acute Care Surg; 2018 Jul; 85(1S Suppl 2):S92-S97. PubMed ID: 29538230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic function of apheresis platelets stored at 4°C and 22°C.
    Reddoch KM; Pidcoke HF; Montgomery RK; Fedyk CG; Aden JK; Ramasubramanian AK; Cap AP
    Shock; 2014 May; 41 Suppl 1(0 1):54-61. PubMed ID: 24169210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed Leukoreduction of whole blood with a platelet-sparing filter to increase low-titer group O whole blood production in the United States.
    Wellington M; Feldman TP; Cleeton S; Sawyer S; Brown BL
    Transfusion; 2023 May; 63 Suppl 3():S177-S188. PubMed ID: 37071767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of leukoreduction on concentrations of interleukin-8, interleukin-1β, and tumor necrosis factor-α in canine packed red blood cells during storage.
    Purcell SL; Claus M; Hosgood G; Smart L
    Am J Vet Res; 2015 Nov; 76(11):969-74. PubMed ID: 26512542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing.
    Schubert P; Culibrk B; Bhakta V; Closas T; Sheffield WP; Devine DV; McTaggart K
    Transfusion; 2022 Aug; 62 Suppl 1():S98-S104. PubMed ID: 35748674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time.
    Pidcoke HF; McFaul SJ; Ramasubramanian AK; Parida BK; Mora AG; Fedyk CG; Valdez-Delgado KK; Montgomery RK; Reddoch KM; Rodriguez AC; Aden JK; Jones JA; Bryant RS; Scherer MR; Reddy HL; Goodrich RP; Cap AP
    Transfusion; 2013 Jan; 53 Suppl 1(0 1):137S-149S. PubMed ID: 23301966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.